U.S. Customs and Border Protection · CROSS Database · 1 HTS code referenced
Primary HTS Code
3004.90.9160
$4641.1M monthly imports
Compare All →
Ruling Age
10 years
Data compiled from CBP CROSS Rulings, Census Bureau Trade Data · As of 2026-04-29 · Updates monthly
The tariff classification of Omeprazole Sodium Bicarbonate in dosage form, from India
N274892 April 22, 2016 CLA-2-30:OT:RR:NC:N2:238 CATEGORY: Classification TARIFF NO.: 3004.90.9160 Ms. Martha Scott 3300 Cork Airport Business Park Kinsale Road Cork T12 XN72 Ireland RE: The tariff classification of Omeprazole Sodium Bicarbonate in dosage form, from India Dear Ms. Scott: In your letter dated April 13, 2016, you requested a tariff classification ruling. Omeprazole Sodium Bicarbonate is a medicinal preparation in capsule form, containing Omeprazole (a proton-pump inhibitor) and Sodium Bicarbonate (antacid), as the active ingredients. It is indicated for the treatment of ulcers, gastroesophageal reflux disease (heartburn) and erosive esophagitis. Omeprazole Sodium Bicarbonate will be imported packed ready for retail sale in dosage form. The applicable subheading for the Omeprazole Sodium Bicarbonate in dosage form will be 3004.90.9160, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Medicaments primarily affecting the digestive system: Other.” The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at https://hts.usitc.gov/current. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Judy Lee at judy.h.lee@cbp.dhs.gov. Sincerely, Deborah C. Marinucci Acting Director National Commodity Specialist Division